These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30275913)

  • 61. [Value of detection of preoperative urinary soluble Fas expression in predicting the recurrence of non-muscle invasive bladder cancer].
    Yang H; Guo Y; Wang Z; Wang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):24-9. PubMed ID: 26819421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer.
    Quhal F; Pradere B; Laukhtina E; Sari Motlagh R; Mostafaei H; Mori K; Schuettfort VM; Karakiewicz PI; Rouprêt M; Enikeev D; Rink M; Abufaraj M; Shariat SF
    World J Urol; 2021 Sep; 39(9):3345-3352. PubMed ID: 33496841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent advances in the metabolomic study of bladder cancer.
    Amara CS; Vantaku V; Lotan Y; Putluri N
    Expert Rev Proteomics; 2019 Apr; 16(4):315-324. PubMed ID: 30773067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis.
    Hou J; Huang H; Xie J; Yu W; Hao H; Li H
    Mol Carcinog; 2024 Feb; 63(2):286-300. PubMed ID: 37888201
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.
    Kaynar M; Yıldırım ME; Badem H; Caviş M; Tekinarslan E; Istanbulluoğlu MO; Karataş ÖF; Çimentepe E
    Tumour Biol; 2014 Jul; 35(7):6601-5. PubMed ID: 24696263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Cytokeratins (UBC and CYFRA 21-1) and nuclear matrix proteins (NMP22) as urine tumor markers in the diagnosis of bladder cancer].
    Sánchez-Carbayo M; Urrutia M; Hernández-Cerceño ML; González de Buitrago JM; Navajo JA
    Med Clin (Barc); 2000 Mar; 114(10):361-6. PubMed ID: 10786344
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder.
    Matsumoto K; Ikeda M; Matsumoto T; Nagashio R; Nishimori T; Tomonaga T; Nomura F; Sato Y; Kitasato H; Iwamura M
    Asian Pac J Cancer Prev; 2014; 15(22):9927-31. PubMed ID: 25520130
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary markers in the surveillance of non-muscle invasive bladder cancer. A literature review.
    Agreda Castañeda F; Raventós Busquets CX; Morote Robles J
    Actas Urol Esp (Engl Ed); 2019 Oct; 43(8):404-413. PubMed ID: 31097210
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer.
    Elsharkawi F; Elsabah M; Shabayek M; Khaled H
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2219-2224. PubMed ID: 31350988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?
    Mahnert B; Tauber S; Kriegmair M; Nagel D; Holdenrieder S; Hofmann K; Reiter W; Schmeller N; Stieber P
    Clin Chem Lab Med; 2003 Jan; 41(1):104-10. PubMed ID: 12636058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
    Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer.
    Garczyk S; Bischoff F; Schneider U; Golz R; von Rundstedt FC; Knüchel R; Degener S
    Virchows Arch; 2021 Aug; 479(2):325-335. PubMed ID: 33650041
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
    Kimura S; Soria F; D'Andrea D; Foerster B; Abufaraj M; Vartolomei MD; Karakiewicz PI; Mathieu R; Moschini M; Rink M; Egawa S; Shariat SF; Gust KM
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1123-e1132. PubMed ID: 30061034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer.
    Azuma T; Sato Y; Ohno T; Azuma M; Kume H
    PLoS One; 2020; 15(12):e0243379. PubMed ID: 33306717
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer.
    Gogalic S; Sauer U; Doppler S; Heinzel A; Perco P; Lukas A; Simpson G; Pandha H; Horvath A; Preininger C
    Biomarkers; 2017 Nov; 22(7):674-681. PubMed ID: 28010124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.